These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7008182)

  • 1. Extreme potassium loss in a patient with severe graft versus host disease.
    Tricot GJ; Zwaan FE; Kauffmann RH; Jansen J; Haak HL
    Scand J Haematol; 1980 Sep; 25(3):264-7. PubMed ID: 7008182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Marrow transplant experience for children with severe aplastic anemia.
    Sanders JE; Storb R; Anasetti C; Deeg HJ; Doney K; Sullivan KM; Witherspoon RP; Hansen J
    Am J Pediatr Hematol Oncol; 1994 Feb; 16(1):43-9. PubMed ID: 8311172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of mixed chimerism on graft-versus-host disease, disease recurrence and survival after HLA-identical marrow transplantation for aplastic anemia or chronic myelogenous leukemia.
    Huss R; Deeg HJ; Gooley T; Bryant E; Leisenring W; Clift R; Buckner CD; Martin P; Storb R; Appelbaum FR
    Bone Marrow Transplant; 1996 Oct; 18(4):767-76. PubMed ID: 8899193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow transplantation for aplastic anaemia from a HL-A and MLC-identical unrelated donor.
    Lohrmann HP; Dietrich M; Goldmann SF; Kristensen T; Fliedner TM; Abt C; Pflieger H; Flad HD; Kubanek B; Heimpel H
    Blut; 1975 Dec; 31(6):347-54. PubMed ID: 1127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone marrow transplantation for severe aplastic anemia. A report of 9 cases.
    Marmont AM; Van Lint MT; Avanzi G; Reali G; Adami R; Soldá A; Strada P; Barbanti M; Mingari MC; Soro O; Grazi G; Pedullá D; Cerri R; Rossi E; Giordano D; Santini G; Carella A; Risso M; Vimercati R; Piaggio G; Raffo MR; Librace E; Vitale V; Bacigalupo A
    Acta Haematol; 1979; 62(3):121-7. PubMed ID: 43062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow transplantation in Fanconi anaemia.
    Gluckman E; Devergie A; Schaison G; Bussel A; Berger R; Sohier J; Bernard J
    Br J Haematol; 1980 Aug; 45(4):557-64. PubMed ID: 7000153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment with prednisone and graft-versus-host disease in an allogeneic bone-marrow transplant recipient.
    Groth CG; Gahrton G; Lundgren G; Möller E; Pihlstedt P; Ringdén O; Sundelin P
    Scand J Haematol; 1979 Apr; 22(4):333-8. PubMed ID: 38500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sclerodermatous graft-versus-host disease limited to an area of measles exanthem.
    Fenyk JR; Smith CM; Warkentin PI; Krivit W; Goltz RW; Neely JE; Nesbit ME; Ramsay NK; Coccia PF; Kersey JH
    Lancet; 1978 Mar; 1(8062):472-3. PubMed ID: 76022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow transplantation for severe aplastic anaemia.
    Darlow BA; Abbott GD; Beard ME; Fox HW; Hamer JW; Heaton DC
    N Z Med J; 1980 Feb; 91(653):86-9. PubMed ID: 6991993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Campath-1G in vivo confers a low incidence of graft-versus-host disease associated with a high incidence of mixed chimaerism after bone marrow transplantation for severe aplastic anaemia using HLA-identical sibling donors.
    Hamblin M; Marsh JC; Lawler M; McCann SR; Wickham N; Dunlop L; Ball S; Davies EG; Hale G; Waldmann H; Gordon-Smith EC
    Bone Marrow Transplant; 1996 May; 17(5):819-24. PubMed ID: 8733704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bone marrow transplantation for aplastic anemia--initial results in 8 patients].
    Hinterberger W; Gadner H; Höcker P; Hajek-Rosenmayr A; Graninger W; Hawlicek R; Stingl G; Bettelheim P; Korninger C; Neumann E; Niessner H; Schmidmeier W; Schroth B; Stellar C; Mayr W; Lechner K
    Wien Klin Wochenschr; 1982 Oct; 94(19):504-9. PubMed ID: 6760559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective trial of mycophenolate mofetil-cyclosporine A prophylaxis for acute GVHD after G-CSF stimulated allogeneic bone marrow transplantation with HLA-identical sibling donors in patients with severe aplastic anemia and hematological malignancies.
    Ostronoff F; Ostronoff M; Souto-Maior AP; Domingues M; Sucupira A; Manso DA; de Lima AK; Monteiro PG; Florêncio R; Calixto R
    Clin Transplant; 2009; 23(1):33-8. PubMed ID: 18727660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Favorable current prognosis after HLA-identical bone marrow transplantation for children with required severe aplastic anemia; evaluation of 30 years of bone marrow transplantation at the Leiden University Medical Center].
    van Steekelenburg M; van Weel-Sipman MH; Zwinderman AH; Hoogerbrugge PM; Vossen JM; Egeler RM
    Ned Tijdschr Geneeskd; 2002 Aug; 146(33):1542-6. PubMed ID: 12212502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Graft versus host reaction and hybrid resistance in experimental models and clinical practice].
    Clerici M; Villa ML; Clerici E
    Boll Ist Sieroter Milan; 1988; 67(3):177-96. PubMed ID: 3072013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone marrow transplantation for patients with acquired severe aplastic anemia using cyclophosphamide and antithymocyte globulin: the experience from a single center.
    Abdelkefi A; Ben Othman T; Ladeb S; Torjman L; Hsaïri M; Ben Abdeladhim A
    Hematol J; 2003; 4(3):208-13. PubMed ID: 12764353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A single centre experience with allogeneic stem cell transplantation for severe aplastic anaemia in childhood.
    Ladenstein R; Peters C; Minkov M; Emminger-Schmidmeier W; Mann G; Höcker P; Hawliczek R; Rosenmayr A; Fink FM; Niederwieser D; Gadner H
    Klin Padiatr; 1997; 209(4):201-8. PubMed ID: 9293451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial Role of Low-Dose Antithymocyte Globulin in Unrelated Stem Cell Transplantation for Adult Patients with Acquired Severe Aplastic Anemia: Reduction of Graft-versus-Host Disease and Improvement of Graft-versus-Host Disease-Free, Failure-Free Survival Rate.
    Park SS; Kwak DH; Jeon YW; Yoon JH; Lee SE; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Min WS; Lee JW
    Biol Blood Marrow Transplant; 2017 Sep; 23(9):1498-1508. PubMed ID: 28554856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporine and graft failure following bone marrow transplantation for severe aplastic anaemia.
    Hows J; Palmer S; Gordon-Smith EC
    Br J Haematol; 1985 Aug; 60(4):611-7. PubMed ID: 3896296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatal GvHD as a complication of liver transplantation for undetermined fulminant hepatic failure and associated aplastic anemia.
    Schäppi MG; Belli DC; Rimensberger PC; Chardot C; Kaya G; Tiercy JM; Ozsahin H
    Liver Transpl; 2006 Nov; 12(11):1693-7. PubMed ID: 17058230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Favorable effect on acute and chronic graft-versus-host disease with cyclophosphamide and in vivo anti-CD52 monoclonal antibodies for marrow transplantation from HLA-identical sibling donors for acquired aplastic anemia.
    Gupta V; Ball SE; Yi QL; Sage D; McCann SR; Lawler M; Ortin M; Freires M; Hale G; Waldmann H; Gordon-Smith EC; Marsh JC
    Biol Blood Marrow Transplant; 2004 Dec; 10(12):867-76. PubMed ID: 15570255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.